SUNLINK HEALTH SYSTEMS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.64 USD | -1.55% |
|
-5.88% | -31.18% |
| 13/02 | SunLink Health Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| 12/02 | North American Morning Briefing : Stock Futures -2- | DJ |
| Sales 2022 | 41.34M 3.45B | Sales 2023 | 47.95M 4B | Capitalization | 6.4M 534M |
|---|---|---|---|---|---|
| Net income 2022 | -2M -167M | Net income 2023 | -1M -83.38M | EV / Sales 2022 | 0.03 x |
| Net cash position 2022 | 5.53M 461M | Net cash position 2023 | 3.4M 284M | EV / Sales 2023 | 0.06 x |
| P/E ratio 2022 |
-3.43
x | P/E ratio 2023 |
-3.5
x | Employees | 1,614 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.07% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | -1.55% | ||
| 1 week | -5.88% | ||
| Current month | -12.33% | ||
| 1 month | -12.33% | ||
| 3 months | -31.91% | ||
| 6 months | -8.70% | ||
| Current year | -31.18% |
1 week
0.60
0.77
1 month
0.600.77
Current year
0.600.98
1 year
0.541.11
3 years
0.535.46
5 years
0.007.62
10 years
0.007.62
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Thornton
CEO | Chief Executive Officer | 75 | 16/96/16 |
Mark Stockslager
DFI | Director of Finance/CFO | 65 | 01/93/01 |
Sheila Brockman
PRN | Corporate Officer/Principal | 64 | 11/19/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Thornton
CEO | Chief Executive Officer | 75 | 16/96/16 |
Steven Baileys
BRD | Director/Board Member | 70 | 01/00/01 |
C. Ford
BRD | Director/Board Member | 85 | 01/99/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.64 | -1.55% | 8,713 |
| 25/24/25 | 0.6501 | +0.02% | 3,712 |
| 24/24/24 | 0.65 | -6.58% | 30,195 |
| 23/24/23 | 0.6958 | -4.68% | 32,425 |
| 22/24/22 | 0.73 | +7.35% | 120,197 |
Delayed Quote Nyse, April 27, 2024 at 01:40 am IST
More quotes
SunLink Health Systems, Inc., through subsidiaries, owns businesses which provide healthcare products and services in certain markets in the southeastern United States. The Company operates through two segments: Healthcare Services and Pharmacy. The Healthcare Services segment subsidiaries owns and operates Trace Regional Medical Center (Trace), a 49-bed community hospital, clinics and a 66-bed nursing home in Mississippi, and an information technology (IT) service company based in Georgia. The Pharmacy segment subsidiary owns and operates a pharmacy business in Louisiana with four operational areas. The operational areas include retail pharmacy products and services provided to residents of southwestern Louisiana; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products; non-institutional pharmacy services; and durable medical equipment (DME) consisting primarily of the sale and rental of products.
Sector
Drug Retailers
Calendar
10/05/2024
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -31.18% | 4.51M | |
| -32.21% | 15.27B | |
| -31.97% | 10.84B | |
| -30.42% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B |
- Stock Market
- Equities
- SSY Stock
